Belpointe Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Belpointe Asset Management's EXAS Position: Q1 2026 in Review
Belpointe Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 18,905 shares — an estimated $1.92M sold.
Belpointe Asset Management first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $5.79M in Q1 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Belpointe Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Belpointe Asset Management sold 18,905 Exact Sciences shares in Q1 2026, an estimated $1.92M.
- Belpointe Asset Management first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
- Belpointe Asset Management's Exact Sciences position peaked at $5.79M in Q1 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.